The Jordanian Stem Cell Company Acquires Stem Cell Technology From Stemedica International S.A. - First Clinical Trail Anticipated To Begin ... (orking with Stemedica International"...)

HOME >> BIOLOGY >> TECHNOLOGY

The Jordanian Stem Cell Company Acquires Stem Cell Technology From Stemedica International S.A. - First Clinical Trail Anticipated To Begin Early 2010

Date:9/7/2009

orking with Stemedica International," said Sam Alkhass. "Jordan has an excellent reputation as a provider of innovative and quality-driven medical treatment. It was fundamental to our company's future, and Jordan's reputation, that we find the best possible partner within the stem cell industry. We believe we have accomplished this objective by securing a long-term exclusive relationship with Stemedica International." Headquartered in Amman, The Jordanian Stem Cell Company is Chaired by His Royal Highness, Prince Asem Bin Nayef.

"We would like to thank the Jordanian Stem Cell Company and its Chairman, His Royal Highness, Prince Asem Bin Nayef for their vision and long-term commitment in bringing adult stem technology to Jordan," said Roger J. Howe, PhD, Chief Executive Officer for Stemedica International and Executive Chairman for Stemedica. "Our working relationship will not only provide significant medical advancements in treating the Citizens of Jordan, but will allow the country to continue to build on its growing reputation as a, "Center of Medical Excellence" for the entire region. We have a quality partner in The Jordanian Stem Cell Company and in the Country of Jordan and we look forward to growing these relationships."

"Stemedica International will be providing our state-of-the-art stem cell technology to the Jordanian Stem Cell Company and will actively support their development and implementation of a Clinical Trial for burns," said Nikolai Tankovich, MD, PhD, Stemedica's President and Chief Medical Officer and Vice Chairman of Stemedica International. "We will work closely with the leadership of the Jordanian Stem Cell Company to secure all necessary governmental approvals for the Clinical Trial. The Trial is anticipated to begin sometime in the first quarter of 2010."

Stemedica International S.A. is a Lausanne, Switzerland-based, w
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
2. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
3. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
4. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
5. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
6. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
7. NASA technology forms the basis for a new nanotechnology company
8. Solazyme, Inc. Selected by AlwaysOn as a GoingGreen 100 Top Private Company Award Winner
9. Abaxis to Present at the Sidoti & Company Sixth Annual San Francisco Institutional Investor Forum Conference
10. Monsanto Company Signs Share Subscription Agreement With Devgen
11. New Orthopedic Surgical Robotics Company Opens Its Doors; Files with the FDA for Clearance of Its Flagship Product

Post Your Comments:

Related Image:

The Jordanian Stem Cell Company Acquires Stem Cell Technology From Stemedica International S.A. - First Clinical Trail Anticipated To Begin Early 2010

(Date:12/16/2009)... 22% for fiscal 2009; on track for positive ... 16 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (MBX:TSX) a ... today reported financial results for fourth quarter and ... 30, 2009, Microbix reported revenues of $6.08 million, ... 2008. For fourth-quarter 2009, the Company saw revenues ...

(Date:12/16/2009)... LLC introduces HSP-A Soy Peptone. HSP A has been found ... ... (PRWEB) December 16, 2009 -- Nu-Tek BioSciences, LLC. ( ... HSP-A Soy Peptone. HSP-A, previously manufactured by Nutricepts, Inc. (Burnsville, ... to improve growth rates and yields. HSP-A has been found ...

(Date:12/15/2009)... /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, Inc. ("China Sky ... ), a,leading fully integrated pharmaceutical company developing and ... ("PRC"), today,announced that the Company has 30 medicines ... the National Basic Medical Insurance, Industrial Injury Insurance,and ... The 30 medicines treat a variety of ...

(Date:12/15/2009)... PLYMOUTH, Minn., Dec. 15 The Mosaic Company (NYSE: ... quarter fiscal year 2010 earnings results and financial tables ... trading on the New York Stock Exchange. Results ... ,, The Company will host a conference call ... discuss the results. The call will begin at ...

Breaking Biology Technology:Microbix' Pipeline Set To Reach Milestones In 2010 2 Microbix' Pipeline Set To Reach Milestones In 2010 3 Microbix' Pipeline Set To Reach Milestones In 2010 4 Microbix' Pipeline Set To Reach Milestones In 2010 5 Microbix' Pipeline Set To Reach Milestones In 2010 6 Microbix' Pipeline Set To Reach Milestones In 2010 7 Microbix' Pipeline Set To Reach Milestones In 2010 8 China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2 China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3 Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2

[0] Microbix' Pipeline Set To Reach Milestones In 2010 [0] Nu-Tek BioSciences, LLC. Launches Animal-Free, Non-GM Soy Peptone [0] China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory [0] Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call

... July 25 Beckman,Coulter, Inc. (NYSE: BEC ... that simplify, automate and innovate complex biomedical,testing, announced ... 30, 2008,results. Total revenue of $798.3 million increased ... was up 11.2%. Net earnings were,$47.8 million, or ...

... Mind Foundation and conducted by TNS Teleseker, revealed that a majority ... methods that could "put them into a creative state and keep ... ... Jerusalem, Israel (PRWEB) July 26, 2008 -- A recent ...

... and SAN DIEGO, July 24 /PRNewswire-FirstCall/ - MIGENIX ... drugs for infectious,diseases, advises that the directors of ... (the "Meeting") to be held at 2:00 p.m. ... 2389 Health Sciences Mall, Vancouver,British Columbia. Further details ...

Beckman Coulter Announces Second Quarter 2008 Results Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science Notice of MIGENIX General Meeting of Shareholders

(Date:12/16/2009)... source of financial and technical assistance to developing countries ... appear to be connected to space technology, but large ... intrinsically linked. , Global climate change is also an ... in the poorest countries and communities, which will suffer ... led to a growing demand for information about the ...

(Date:12/16/2009)... than 4 billion years before humans showed up, and ... That suggests they may have something to teach us. ... Prof. Eshel Ben-Jacob of the Raymond and Beverly Sackler ... of bacteria, presents compelling evidence to suggest there may ... opt for the swine flu H1N1 shot. , In ...

(Date:12/16/2009)... SUNNYVALE, Calif., Dec. 1 GestureTek ... CUBE, Release 3.0 - a turnkey, portable, ... for advertising, exhibits, entertainment and touring promotions. ... dozens of patents in camera-enabled gesture recognition ... systems. ,, Guaranteed for quality, the CUBE ...

Breaking Biology News(10 mins):ESA and World Bank move toward closer collaboration 2 ESA and World Bank move toward closer collaboration 3 ESA and World Bank move toward closer collaboration 4 Bacteria wouldn't opt for a swine flu shot 2 Bacteria wouldn't opt for a swine flu shot 3 GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2 GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3 The Leukemia 26 Lymphoma Society and FORMA Therapeutics Enter Collaboration to Bring New Therapies to Patients Faster 52091 1 The Leukemia 26 Lymphoma Society and FORMA Therapeutics Enter Collaboration to Bring New Therapies to Patients Faster 52091 2 The Leukemia 26 Lymphoma Society and FORMA Therapeutics Enter Collaboration to Bring New Therapies to Patients Faster 52091 3 Group Health Cooperative Scored Above Regional Average in 11 of 15 Quality Measures 52086 1 Group Health Cooperative Scored Above Regional Average in 11 of 15 Quality Measures 52086 2 Oncolytics Biotech 28R 29 Inc Completes Lyophilization Process for REOLYSIN 28R 29 13083 1 Oncolytics Biotech 28R 29 Inc Completes Lyophilization Process for REOLYSIN 28R 29 13083 2

[0] ESA and World Bank move toward closer collaboration [0] Bacteria wouldn't opt for a swine flu shot [0] GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits

... marine biologists will gather in Auckland from 14-16 November to ... to the tropics. This major meeting of a global marine ... jointly hosted by the National Institute of Water & Atmospheric ... The Census of Marine Life is a ten-year initiative to ...

... confused feelings that occur when you meet someone whose ... his or her gender., A new study by neuroscientists ... processing of such sensory information about anothers gender to ... study concludes that it does, weighing in with findings ...

... There are many historical stories of shepherds and travellers ... of tales about attacks on flocks and people by ... of their former range, but for livestock owners around ... a daily reality. Although loss of human life is ...

Other Biology News:Hearing changes how we perceive gender 2 Hearing changes how we perceive gender 3 Hearing changes how we perceive gender 4 Living with lions 2

Scientists gather in New Zealand to share oceans' secrets Hearing changes how we perceive gender Living with lions

... Vesicular Monoamine Transporter 2 (VMAT2). An antibody ... a major band at ~55 kDa in ... and not in wild type cells (2). ... molecular weight, were also detected and remain ...

... INK4a-ARF locus encodes two unrelated proteins both ... arrests the cell cycle in a p53-dependent ... the rapid degradation of mdm2 proteinrequired for ... accumulation. This interaction is mediated by ...

... immunoblotting the antibody reacts against the reduced ... MMP-2 or MMP-2 bound to TIMP-2. affinity ... Solution in 0.01 M phosphate buffered ... 15 mM sodium azide. synthetic peptide corresponding ...

... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. Mfr Desig: ...

Biology Products:

Anti-Vesicular Monoamine Transporter 2 (VMAT2) Polyclonal Antibody, Unconjugated from CHEMICON Mouse Anti-p14 ARF / p16Beta Ab-2 Mouse Monoclonal Antibody, Unconjugated, Clone 14P02 from Lab Vision Rabbit Anti-Matrix Metalloproteinase-2, Hinge Region Antibody, Unconjugated from Sigma-Aldrich Corning Culture Flask, 150 cm2, Tc-Treated, Angled Neck, Phenolic-Style, Sterile from Sigma-Aldrich

The Jordanian Stem Cell Company Acquires Stem Cell Technology From Stemedica International S.A. - First Clinical Trail Anticipated To Begin ...(orking with Stemedica International"...)